Comparison of histological lesion scores of lungs and brains from PRV-WT and PRV-UL4^mut infected piglets. حسب Xiaohua Zhang (350570)

الموضوعات:

The UL4 mutation alleviated inflammation in PRV-infected mice. حسب Xiaohua Zhang (350570)

الموضوعات:

Data for Fig 5D. حسب Xiaohua Zhang (350570)

الموضوعات:

The UL4 mutation alleviated inflammasome activation and pyroptosis in PRV-infected cells. حسب Xiaohua Zhang (350570)

الموضوعات:

PRV UL4 is a promotor of NLRP3 inflammasome activation. حسب Xiaohua Zhang (350570)

الموضوعات:

The UL4 null mutation alleviated inflammasome activation in PRV-infected cells. حسب Xiaohua Zhang (350570)

الموضوعات:

PRV UL4 is a promotor of NLRP3 inflammasome Activation. حسب Xiaohua Zhang (350570)

الموضوعات:

Sequence of UL4 is involved in inflammasome activation. حسب Xiaohua Zhang (350570)

الموضوعات:

PRV UL4 protein facilitates ASC oligomerization and speck formation by promoting ASC phosphorylation. حسب Xiaohua Zhang (350570)

الموضوعات:

Data for Figs S1A–S1C, S2A, S2C–S2L, S3C–S3F, S4A–S4J. حسب Xiaohua Zhang (350570)

الموضوعات:

Data for Figs 1A–1I, 2A–2J, 3B–3H, 4A–4L, 5A–5C, 6A–6C, 6E, حسب Xiaohua Zhang (350570)

الموضوعات:

Data for Figs 8A–8H, 9A–9K, 10A–10I. حسب Xiaohua Zhang (350570)

الموضوعات:

Viral UL4 protein promotes pyroptosis in macrophage cells. حسب Xiaohua Zhang (350570)

الموضوعات:

The UL4 mutation alleviates inflammation in PRV-infected pigs. حسب Xiaohua Zhang (350570)

الموضوعات:

PRV UL4 augments ASC oligomerization and speck formation. حسب Xiaohua Zhang (350570)

الموضوعات:

PRV UL4 interacts with ASC. حسب Xiaohua Zhang (350570)

الموضوعات:

The UL4 null mutation alleviates inflammasome activation in PRV-infected cells. حسب Xiaohua Zhang (350570)

الموضوعات:

Levels of OVA-specific IgE and IgG1 in serum from different groups of mice. حسب Guoqing Meng (4669774)

الموضوعات:

Overview over the contents of the app program divided by level [28]. حسب Anton Kurapov (11346019)

الموضوعات:

Heterogeneity test at different educational levels. حسب Yanling Li (269030)

الموضوعات: